Finance

Roʻyxatlar
DAP:ETR
Danaher Corp
208,90 €
-1,46%
(-3,10) 1K
13-noy, 17:35:43 (GMT+1)  ·   EUR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
DAP tikeri uchun statistika yaratilmoqda...
Ochish
210,30 €
Yuqori
211,00 €
Past
208,70 €
Bozor kapitali
163,94 mlrd
Oʻrtacha hajm
549,00
Hajmi
426,00
52 haftalik eng yuqori
214,50 €
52 haftalik eng past
138,20 €
Xodimlar soni
59 ming
Ochish
210,30 €
Yuqori
211,00 €
Past
208,70 €
Bozor kapitali
163,94 mlrd
Oʻrtacha hajm
549,00
Hajmi
426,00
52 haftalik eng yuqori
214,50 €
52 haftalik eng past
138,20 €
Xodimlar soni
59 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Danaher Corp haqida
CEORainer M. Blair
Xodimlar soni59 ming
Asos solingan1969
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytdanaher.com
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
dek, 2025
mar, 2026
iyn, 2026
sen, 2026
Daromad
6,84 mlrd
5,95 mlrd
6,26 mlrd
6,55 mlrd
Sotilgan mahsulotning tannarxi
2,86 mlrd
2,36 mlrd
2,61 mlrd
2,58 mlrd
Daromad narxi
2,86 mlrd
2,36 mlrd
2,61 mlrd
2,58 mlrd
Tadqiqot va ishlanmalarga xarajatlar
438,00 mln
387,00 mln
412,00 mln
433,00 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
2,03 mlrd
1,84 mlrd
2,01 mlrd
2,16 mlrd
Operatsion xarajatlar
2,46 mlrd
2,23 mlrd
2,42 mlrd
2,59 mlrd
Jami operatsion xarajatlar
5,32 mlrd
4,59 mlrd
5,03 mlrd
5,17 mlrd
Operatsion daromad
1,52 mlrd
1,36 mlrd
1,24 mlrd
1,38 mlrd
Boshqa nooperatsion daromad
-87,00 mln
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,37 mlrd
1,24 mlrd
1,08 mlrd
1,13 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,39 mlrd
1,33 mlrd
1,19 mlrd
1,28 mlrd
Daromad soligʻi boʻyicha xarajat
190,00 mln
206,00 mln
208,00 mln
-75,00 mln
Amaldagi soliq stavkasi
13,84%
16,68%
19,29%
-6,63%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
1,20 mlrd
1,03 mlrd
870,00 mln
1,24 mlrd
Sof foyda marjasi
17,51%
17,29%
13,89%
18,84%
Har bir aksiya foydasi
2,23
2,06
1,94
2,11
Foizlar va investitsiyalardan olingan daromadlar
13,00 mln
27,00 mln
61,00 mln
31,00 mln
Foizlarni toʻlash xarajatlari
-55,00 mln
-63,00 mln
-107,00 mln
-135,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-42,00 mln
-36,00 mln
-46,00 mln
-104,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
2,14 mlrd
1,99 mlrd
1,90 mlrd
2,11 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
9,00 mln
-
-
-
Kelgusi tadbirlar
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari